NCT02755272: A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer |
|
|
| Active, not recruiting | 2 | 87 | US | Pembrolizumab, MK-3475, Keytruda, Carboplatin, Paraplatin, Gemcitabine, Gemzar | Fox Chase Cancer Center, University of Wisconsin, Madison | Carcinoma Breast Stage IV | 05/25 | 05/26 | | |
ELU-FRα-1, NCT05001282: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) |
|
|
| Terminated | 1/2 | 79 | US | ELU001, FA-CDC | Elucida Oncology | Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Endometrial Cancer, Ovary Cancer, Ovary Neoplasm, Ovary Disease, Ovary Metastasis, Ovarian Diseases, Ovarian Cancer Stage, Ovarian Epithelial Cancer, Ovarian Adenocarcinoma, Ovarian Serous Adenocarcinoma, Ovarian Neoplasm Epithelial, Ovarian Cancer Recurrent, Endometrial Diseases, Endometrial Adenocarcinoma, Endometrial Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrioid Adenocarcinoma, Endometrial Neoplasms, Endometrial Cancer Recurrent, Endometrioid Tumor, Fallopian Tube Cancer, Peritoneal Cancer | 06/24 | 06/24 | | |
